Abstract:
An active antenna, a base station, a method for refreshing the amplitude and phase, and a signal processing method are disclosed to simplify the structure of a phase shifter and guarantee the reliability of the phase shifter. The active antenna or the base station includes an antenna dipole array, a transceiver array, a digital processing unit (DPU), and a transceiving calibration unit. During signal reception, the transceiver demodulates a radio frequency (RF) signal of the antenna dipole into an IQ analog signal, and outputs the IQ analog signal to the DPU; the DPU converts the demodulated IQ analog signal into an IQ digital signal, and performs digital beam forming (DBF) on the IQ digital signal according to the transceiving calibration unit; during signal transmission, the transceiver modulates the IQ analog signal of the DPU into an RF signal, and outputs the RF signal to the antenna dipole; the DPU converts a signal of a base band unit (BBU) into an IQ digital signal in serial/parallel (S/P) mode, and performs DBF on the IQ digital signal according to the transceiving calibration unit.
Abstract:
Provided herein are steroidal compounds that are androsta-5,7-dienes or pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof and cholecalciferol derivatives hydroxylated at one or more of C1, C17, C20, C23, C24, C25, and C26 which includes pharmaceutical, cosmeceutical or nutraceutical compositions of the steroidal compounds as shown in Tables 1A, 2A and 3. Also provided is a method for producing hydroxylated metabolites of cholecalciferol via CYP11A1, CYP24, CYP27A1, or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C1 or C20 or other position of the sidechain of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. Methods are provided for inhibiting proliferation of either a normally or abnormally proliferating cell, for modifying immune activity, or for treating a condition associated with the proliferating or quiescent cell or immune cells by contacting the cell with or administering any of the compounds described herein.
Abstract:
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
Abstract:
Provided herein are steroidal compounds that are androsta-5,7-dienes or a pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof which includes pharmaceutical compositions of the steroidal compounds as shown in Tables 1 and 2. Also provided is a method for producing hydroxylated metabolites of cholecalciferol or ergocalciferol via the P450scc (CYP11A1) or CYP27B1 enzyme systems where the hydroxylase has an activity to hydroxylate position C20 of a secosteroid or its 5,7-dieneal precursor and the hydroxylated metabolites so produced. In addition, a method for inhibiting proliferation of either a normally or abnormally proliferating cell by contacting the cell with any of the compounds described herein. A related method is provided of treating a condition associated with the proliferating cell such as a cancer, a skin disorder, a defect in cell differentiation, cosmetic, prophylaxsis, or healthy cell maintenance.
Abstract:
Individual multipath components of digital data symbols sent from a transmitter on at least two carrier frequencies generated from a common clock signal, are received (401) with individual delays and processed by a receiver unit having at least two fingers. Successive channel estimates are determined (402) from received symbols for each finger and each carrier, and an estimated frequency error is determined (404) for each finger and each carrier. A linear equation system is constructed (405), in which each determined frequency error is expressed as a function of a first variable indicative of frequency drift and a second variable indicative of frequency error caused by Doppler effect. The equation system is solved (406) to provide a solution with estimates of the first and second variables for each finger, and an estimated frequency drift is determined (407) from the solution and utilized (408) as feedback signal for adjusting receiver clock frequency.
Abstract:
A new Epipremnum plant particularly distinguished by having compact and dense growth habit, dark green leaves that are wider, in relation to length, than other cultivars, vines with large diameters, and vines with shorter internodes, is disclosed.
Abstract:
The subject invention relates to systems and methods that automatically create, update, and use statistics over complex objects within a database query processor. A system is provided that facilitates employment of statistics in connection with database optimization. The system includes a component that receives information relating to database performance and an optimization component that automatically identifies, from the information, a minimal set of statistics to employ in a query. A loader dynamically loads and employs the set of statistics during a query optimization process. The optimization component can employ the statistics over computed columns, whereby the columns can be computed from persisted and non-persisted data.
Abstract:
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
Abstract:
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.